Gain Therapeutics Inc
Gain Therapeutics Inc (GANX) Straddle
GANX straddle scan found 5 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 54.1%.
Read more
Trading a GANX straddle lets you take a pure volatility position on Gain Therapeutics Inc without committing to a direction. Gain Therapeutics Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate GANX straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on GANX profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Gain Therapeutics Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the GANX straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietary small molecules that bind these sites, restore protein folding, and treat disease. It is developing structurally targeted allosteric regulator candidates to treat various diseases, including Morquio B, GM1 gangliosidosis (GM1), neuronopathic Gaucher disease, GBA1 Parkinson's, Krabbe, and Mucopolysaccharidosis type 1 diseases.
The company was founded in 2017 and is based in Bethesda, Maryland.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the GANX straddle is the cleanest expression of that view. Our scanner prices every GANX straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a GANX straddle into a catalyst or short a GANX straddle to harvest decay, the options straddle setups that matter are all in one place.
| May 21, 2027 | 5.00 | $3.85 | 241 | 6% | 54.1% | $8.85 | $1.15 | 0 |
| Nov 20, 2026 | 2.00 | $0.68 | 59 | 6% | 52.1% | $2.68 | $1.33 | 9 |
| May 21, 2027 | 4.00 | $3.00 | 241 | 6% | 50.6% | $7.00 | $1.00 | 0 |
| May 21, 2027 | 3.00 | $2.10 | 241 | 6% | 50.3% | $5.10 | $0.90 | 0 |
| May 21, 2027 | 2.00 | $1.65 | 241 | 6% | 28.0% | $3.65 | $0.35 | 0 |
As of September 22, 2026
Find the right straddle before volatility moves
Track GANX straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.
Start your 14-day free trial→